Delivery Order SPE2DB25D3002-SPE2DB25FLRNU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,113.14 to AmerisourceBergen Drug Corp for the supply of Levocetirizine 2.5 mg/5 ml oral solution in 148 ml containers. This contract, executed on August 5, 2025, with a completion deadline of August 6, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Levocetirizine 2.5 mg/5 ml solution in 148 ml bottles, with a ceiling value of $2,771.76 and a period of performance through May 1, 2025. The contract is not set aside and was awarded on April 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $20,130 to Amerisourcebergen Drug Corporation for 4561741950 Levocetirizine 5 mg tablets. The order is for 90 units of the specified medication to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and performed within the period of August 8-9, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports the Defense...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,394.77 for 500 tablets of Cetirizine HCL 10 mg on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $5,133.56 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of 500 tablets of Cetirizine HCL 10 mg. This competitively awarded, firm fixed-price contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical delivery will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count units) on September 10, 2025, with a ceiling value of $4,911.62 and ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,528.93 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg, with an ultimate completion date of July 24, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to supply pharmaceutical products supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count packages) with a ceiling value of $7,861.18. This firm fixed price delivery order, with an ultimate completion date of September 17, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was awarded on a competitive basis with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $2,165.37 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count packages). The contract is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was not set aside for any specific business category and was competitively awarded. AmerisourceBergen Drug Corp,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,724.96 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA and carries no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken,...
- SPE2DB25D3002Indefinite Delivery Contract
- SPE2DB25D3002-SPE2DB25FLRNUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,842.26 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Levocetirizine 2.5 mg/5 ml solution in a 148 ml quantity. The contract utilizes firm fixed price terms and is scheduled for completion by September 29, 2025. This delivery order was awarded through competitive procedures with no set-aside designation, reflecting the vendor's demonstrated capability to meet federal pharmaceutical procurement requirements. The performance location is established at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a leading pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceutical products to support military healthcare systems. The broader IDC vehicle supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally, enabling flexible fulfillment of diverse pharmaceutical and medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/26/25 |